Cover Image

The role of diallyl thiosulfinate associated with nuciferine and diosgenin in the treatment of premature ejaculation: A pilot study

Tommaso Cai, Andrea Cocci, Gianmartin Cito, Bruno Giammusso, Alessandro Zucchi, Francesco Chiancone, Maurizio Carrino, Francesco Mastroeni, Francesco Comerci, Girgio Franco, Alessandro Palmieri
  • Tommaso Cai
    Department of Urology, Santa Chiara Regional Hospital, Trento, Italy | ktommy@libero.it
  • Andrea Cocci
    Department of Urology, University of Florence, Florence, Italy
  • Gianmartin Cito
    Department of Urology, University of Florence, Florence, Italy
  • Bruno Giammusso
    Department of Andrology, Policlinico Morgagni, Catania, Italy
  • Alessandro Zucchi
    Department of Urology, University of Perugia, Perugia, Italy
  • Francesco Chiancone
    Department of Urology, Cardarelli Hospital, Naples, Italy
  • Maurizio Carrino
    Department of Urology, Cardarelli Hospital, Naples, Italy
  • Francesco Mastroeni
    Department of Urology, Azienda Ospedaliera Papardo, Messina, Italy
  • Francesco Comerci
    Urologist, Bologna, Italy
  • Girgio Franco
    Department of Urology, Sapienza University of Rome, Italy
  • Alessandro Palmieri
    Department of Urology, University of Naples, Federico II, Naples, Italy

Abstract

Objective: To assess the efficacy and safety of an association of diallyl thiosulfinate with nuciferine and diosgenin in the treatment of a group of patients suffering from premature ejaculation (PE), primary or secondary to erectile dysfunction (ED).
Materials and methods: From July 2015 to October 2016, 143 patients (mean age 25.3; range 18-39) affected by PE completed the study and were finally analyzed in this phase I study. All patients, after clinical assessment and laboratory evaluation were asked to take an association of diallyl thiosulfinate with nuciferine and diosgenin as oral tablet, once a day, on alternate days, for three months. At the baseline and after three months of treatment, each patient was asked to complete the following questionnaires: International Index of Erectile Function (IIEF-5), Premature Ejaculation Diagnostic Tool (PEDT), Male Sexual Health Questionnaire (MSHQ).
Results: A statistical significant improvement in terms of erectile function, comparing the IIEF-5 value at baseline and follow- up visit was found (respectively IIEF-5: 8.7 vs 14.01; p < 0.001). Moreover, at follow-up visit, 97/143 men (67.8%) referred a subjective improvement of the erection quality and a better control of the ejaculation (PROs). The IELT improved too between the baseline evaluation and the follow-up visit (p < 0.001).
Conclusion: In conclusion, our study, even if supported by preliminary results, showed how Diallyl Thiosulfinate, Nuciferine and Diosgenin is able to improve the control of ejaculation in patients suffering from PE, primary or secondary to ED without any significant adverse effects.

Keywords

Diosgenin; Muciferine; Thiosulfinate; Plant extracts; Premature ejaculation; Treatment

Full Text:

PDF
Submitted: 2017-12-06 12:41:50
Published: 2018-03-31 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
314

Views:
PDF
83

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2018 Tommaso Cai, Andrea Cocci, Gianmartino Cito, Bruno Giammusso, Alessandro Zucchi, Francesco Chiancone, Maurizio Carrino, Francesco Mastroeni, Francesco Comerci, Girgio Franco, Alessandro Palmieri

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy